Cefdinir 300 mg is a moderately strong antibiotic. It belongs to the third-generation cephalosporin class, which places it a step above common first-line antibiotics like amoxicillin in terms of the range of bacteria it can kill. But it’s specifically designed for mild to moderate infections, not severe or life-threatening ones. If your doctor prescribed it, it’s because the infection you have falls squarely within what cefdinir handles well.
Where Cefdinir Fits Among Antibiotics
Antibiotics are sometimes loosely ranked by “generation,” especially within the cephalosporin family. First-generation cephalosporins cover a narrower set of bacteria. Second-generation drugs expand that coverage. Third-generation cephalosporins like cefdinir go further still, with stronger activity against certain bacteria that have developed defenses against older drugs.
One of cefdinir’s advantages is that it can kill bacteria that produce an enzyme called beta-lactamase, which is a common trick bacteria use to destroy older antibiotics like amoxicillin. That makes cefdinir effective in situations where simpler drugs might fail. However, it’s still an oral medication taken at home, not a hospital-grade intravenous antibiotic. Think of it as a solid middle-tier option: stronger than basic penicillin-type drugs for many infections, but not the most powerful tool available.
What Cefdinir 300 mg Is Prescribed For
The FDA has approved cefdinir for a specific list of mild to moderate infections in adults and adolescents:
- Sinus infections (acute bacterial sinusitis)
- Community-acquired pneumonia
- Flare-ups of chronic bronchitis
- Strep throat and tonsillitis
- Skin infections (uncomplicated, like cellulitis or infected wounds)
In children, it’s also commonly used for ear infections. The key phrase in the FDA labeling is “mild to moderate.” Cefdinir is not intended for serious infections like bloodstream infections, meningitis, or deep tissue infections that require stronger, often intravenous, antibiotics.
How Well It Actually Works
Clinical trials give a concrete picture of cefdinir’s effectiveness. In two large multicenter studies of acute bacterial sinusitis, cefdinir achieved clinical success rates of 89 to 90% when evaluated three to five weeks after treatment. For comparison, amoxicillin-clavulanate, a commonly prescribed combination antibiotic considered a first-line choice for sinus infections, achieved a 92% success rate in the same trials. The difference was not statistically significant.
In other words, cefdinir performs on par with one of the most trusted antibiotics for respiratory infections. It’s not weaker in practice, even if it’s sometimes viewed as a second-choice option. For strep throat and uncomplicated skin infections, cure rates are similarly high.
Standard Dosing for Adults
The typical adult dose is 300 mg taken every 12 hours, or 600 mg taken once daily. Treatment courses generally last 5 to 10 days depending on the type of infection. Your prescriber chose the duration based on what you’re being treated for: strep throat courses tend to be 10 days, while sinus infections and bronchitis flare-ups may be 5 to 10 days.
Finishing the full course matters even if you feel better after a few days. Stopping early can leave behind bacteria that are harder to kill next time.
The Iron Interaction You Should Know About
Cefdinir has an unusually strong interaction with iron. If you take iron supplements, prenatal vitamins containing iron, or iron-fortified foods close to your dose, cefdinir forms a chemical bond with the iron in your gut that blocks absorption dramatically. In one pharmacokinetic study, taking cefdinir alongside an iron supplement reduced the amount of drug absorbed by 93%. Even spacing them three hours apart still reduced absorption by about 36%.
If you take iron supplements, separate them from your cefdinir dose by at least two hours before or after, and ideally longer. Antacids containing aluminum or magnesium can cause a similar, though less severe, problem. This interaction is also the reason cefdinir sometimes turns stool a reddish color when taken with iron. It’s harmless but can be alarming if you’re not expecting it.
Limitations to Keep in Mind
Cefdinir is effective against a specific set of bacteria, not all of them. It works well against common respiratory pathogens and certain skin bacteria, but it has gaps. It only covers strains of Streptococcus pneumoniae (a leading cause of pneumonia and sinusitis) that are susceptible to penicillin. If you have a penicillin-resistant strain, cefdinir may not be strong enough.
It also doesn’t cover atypical bacteria like Mycoplasma or Chlamydophila, which cause a significant portion of walking pneumonia cases. And it has no activity against MRSA, despite being effective against regular Staph aureus skin infections. These aren’t flaws so much as boundaries. Every antibiotic has a defined spectrum, and your prescriber matched cefdinir to the bacteria most likely causing your infection.
If your symptoms aren’t improving after two to three days on cefdinir, that’s worth a follow-up conversation. It could mean the bacteria involved aren’t susceptible, or that the infection is more complex than initially suspected.